Triple-negative breast cancer (TNBC) is a breast cancer (BC) subtype that lacks expression of estrogen receptor (ER), progesterone receptor (PR), and HER2 and accounts for 15–20% of BC cases worldwide. This evidence concerns the gene PGR and triple-negative breast carcinoma.